drugset / Trial / NCT02003638

Assessment Of Vascular Health After Niacin Therapy (AVANT)

NCT02003638

Completed 9 enrolled University of Pennsylvania
RandomizedParallel-groupDouble-blind

Summary

This study is looking to see if niacin will lessen atherosclerotic plaque inflammation and favorably affect circulating levels of endothelial progenitor cells and microparticles in people with atherosclerotic disease on chronic statin therapy.

Timeline

Start
2012-03
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Niacin Small molecule 6000 mg Oral